A Novel Gliotransmitter, L-β-Aminoisobutyric Acid, Contributes to Pathophysiology of Clinical Efficacies and Adverse Reactions of Clozapine
Clozapine is listed as one of the most effective antipsychotics and has been approved for treating treatment-resistant schizophrenia (TRS); however, several type A and B adverse reactions, including weight gain, metabolic complications, cardiotoxicity, convulsions, and discontinuation syndromes, exi...
Main Authors: | Kouji Fukuyama, Eishi Motomura, Motohiro Okada |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/13/9/1288 |
Similar Items
-
Enhanced L-β-Aminoisobutyric Acid Is Involved in the Pathophysiology of Effectiveness for Treatment-Resistant Schizophrenia and Adverse Reactions of Clozapine
by: Kouji Fukuyama, et al.
Published: (2023-05-01) -
Activation of Astroglial Connexin Is Involved in Concentration-Dependent Double-Edged Sword Clinical Action of Clozapine
by: Kouji Fukuyama, et al.
Published: (2020-02-01) -
Dysfunction of the NMDA Receptor in the Pathophysiology of Schizophrenia and/or the Pathomechanisms of Treatment-Resistant Schizophrenia
by: Ruri Okubo, et al.
Published: (2024-09-01) -
Effective and underprescribed: what about clozapine?
by: Helge H.O. Müller
Published: (2017-10-01) -
Dealing With Clozapine-Induced Sialorrhea
by: J. Sá Couto, et al.
Published: (2022-06-01)